As mentioned by others but clearing beta amyloid and reversing cognitive decline in a mice has been done before. Beta amyloid as a target has failed again and

As mentioned by others but clearing beta amyloid and reversing cognitive decline in a mice has been done before. Beta amyloid as a target has failed again and again, and the PDUFA for Aducanamb (mentioned at the end of the article) will likely end in rejection given the scathing adcom.